BioMelbourne Network's 6th Annual Devices + Diagnostics Lab

At BioMelbourne Network's 6th Annual Devices + Diagnostics Lab event this morning, our colleague, Dr Andre Tan introduced HistoIndex’s foray into Melbourne with its new stain-free digital pathology systems to guide fibrosis research, and highlighted two significant announcements:

1) The development of FibroIndex©, a new and advanced image analysis research tool that provides detailed, quantifiable measures of tissue features obtained from our Genesis®200.

2) Two of Melbourne’s leading universities are the first to adopt Genesis®200, the world’s first fully automated, stain-free digital pathology system, coupled with FibroIndex©. As key research groups specialising in fibrosis in Melbourne, the universities are potential preclinical research reference laboratories for researchers, beyond liver/kidney fibrosis, in areas such as cancer, biomaterials and stem-cell therapies.

We would like to offer our utmost gratitude to the BioMelbourne Network team of organisers and sponsors for kindly having us at this event, which we see as a platform that advocates the importance of medical technology and how it accelerates the improvement of care and outcome in the healthcare arena.

Slide2 sm2


Histoindex Pte Ltd @HistoIndexAU #DDL2018


Our site uses cookies or similar technologies to recognise your repeated visits and preferences for us to deliver an optimal browsing experience. Please remember to read our privacy statement.

By clicking on "I Accept" or "X" to continue your browsing on this site, you consent to the use of the cookies. To find out how you can disable cookies on your device, please click here.

I Accept